[SGMO] QoQ Quarter Result on 30-Sep-2024 [#Q3]

Stock
[SGMO] Sangamo Therapeutics, Inc.
Announcement Date
12-Nov-2024
Financial Year
2024
Quarter
30-Sep-2024 [#Q3]
Profit Trend
QoQ- 129.54%
YoY- 110.25%
Quarter Report
SGMO's Result
SGMO's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Revenue 49,412 356 481 2,042 9,398 6,835 157,957 -53.82%
PBT 10,760 -36,054 -48,991 -60,568 -102,893 -120,770 21,327 -36.54%
Tax 88 74 98 -272 1,270 -6,264 194 -40.87%
NP 10,672 -36,128 -49,089 -60,296 -104,163 -114,506 21,133 -36.50%
Tax Rate -0.82% - - - - - -0.91% -
Total Cost 38,740 36,484 49,570 62,338 113,561 121,341 136,824 -56.78%
Ratio Analysis
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
NP Margin 21.60 -10,148.31 -10,205.61 -2,952.79 -1,108.35 -1,675.29 13.38 37.49%
Per Share
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
EPS 0.04 -0.18 -0.27 -0.34 -0.59 -0.66 0.13 -54.32%
EPS Diluted 0.04 -0.18 -0.27 -0.34 -0.59 -0.66 0.12 -51.82%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.